Search Results - "Contarelli, Serena"

  • Showing 1 - 16 results of 16
Refine Results
  1. 1

    Targeting KRAS: The Elephant in the Room of Epithelial Cancers by Merz, Valeria, Gaule, Marina, Zecchetto, Camilla, Cavaliere, Alessandro, Casalino, Simona, Pesoni, Camilla, Contarelli, Serena, Sabbadini, Fabio, Bertolini, Monica, Mangiameli, Domenico, Milella, Michele, Fedele, Vita, Melisi, Davide

    Published in Frontiers in oncology (11-03-2021)
    “…Mutations of the proto-oncogene KRAS are the most frequent gain-of-function alterations found in cancer. KRAS is mutated in about 30% of all human tumors, but…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5

    Novel Biomarkers for Prediction of Response to Preoperative Systemic Therapies in Gastric Cancer by Cavaliere, Alessandro, Merz, Valeria, Casalino, Simona, Zecchetto, Camilla, Simionato, Francesca, Salt, Hayley Louise, Contarelli, Serena, Santoro, Raffaela, Melisi, Davide

    Published in Journal of gastric cancer (01-12-2019)
    “…Preoperative chemo- and radiotherapeutic strategies followed by surgery are currently a standard approach for treating locally advanced gastric and…”
    Get full text
    Journal Article
  6. 6

    Novel Biomarkers for Prediction of Response to Preoperative Systemic Therapies in Gastric Cancer by Cavaliere, Alessandro, Merz, Valeria, Casalino, Simona, Zecchetto, Camilla, Simionato, Francesca, Salt, Hayley Louise, Contarelli, Serena, Santoro, Raffaela, Melisi, Davide

    Published in Journal of gastric cancer (2019)
    “…Preoperative chemo- and radiotherapeutic strategies followed by surgery are currently a standard approach for treating locally advanced gastric and…”
    Get full text
    Journal Article
  7. 7

    HOX Genes Family and Cancer: A Novel Role for Homeobox B9 in the Resistance to Anti-Angiogenic Therapies by Contarelli, Serena, Fedele, Vita, Melisi, Davide

    Published in Cancers (08-11-2020)
    “…Angiogenesis is one of the hallmarks of cancer, and the inhibition of pro-angiogenic factors and or their receptors has become a primary strategy for cancer…”
    Get full text
    Journal Article
  8. 8
  9. 9

    The Multifaceted Role of TGF-β in Gastrointestinal Tumors by Sabbadini, Fabio, Bertolini, Monica, De Matteis, Serena, Mangiameli, Domenico, Contarelli, Serena, Pietrobono, Silvia, Melisi, Davide

    Published in Cancers (05-08-2021)
    “…Transforming growth factor-beta (TGF-β) is a secreted cytokine that signals via serine/threonine kinase receptors and SMAD effectors. Although TGF-β acts as a…”
    Get full text
    Journal Article
  10. 10

    Clinical Response to Futibatinib in Patients with High-Level FGFR2-Amplified Advanced Gastric Cancer: Two Case Reports by Quinzii, Alberto, Zecchetto, Camilla, Casalino, Simona, Gaule, Marina, Pesoni, Camilla, Merz, Valeria, Contarelli, Serena, Pietrobono, Silvia, Benhadji, Karim A., Melisi, Davide

    Published in Clinical drug investigation (01-08-2022)
    “…Genomic alterations responsible for a ligand-independent activation of these tyrosine kinases receptors, including activating point mutations, amplifications,…”
    Get full text
    Journal Article
  11. 11

    The intrinsically disordered E-domains regulate the IGF-1 prohormones stability, subcellular localisation and secretion by Annibalini, Giosuè, Contarelli, Serena, De Santi, Mauro, Saltarelli, Roberta, Di Patria, Laura, Guescini, Michele, Villarini, Anna, Brandi, Giorgio, Stocchi, Vilberto, Barbieri, Elena

    Published in Scientific reports (11-06-2018)
    “…Insulin-like growth factor-1 (IGF-1) is synthesised as a prohormone (proIGF-1) requiring enzymatic activity to yield the mature IGF-1. Three proIGF-1s are…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Abstract 1064: Targeting stromal autotaxin synergizes with TGF beta inhibition in pancreatic cancer by Sabbadini, Fabio, Bertolini, Monica, Mangiameli, Domenico, Contarelli, Serena, Johnson, Zoë, Lahn, Michael M., Pietrobono, Silvia, Melisi, Davide

    Published in Cancer research (Chicago, Ill.) (15-06-2022)
    “…The TGFβ receptor inhibitor galunisertib (GAL) has been demonstrated as an effective strategy for the treatment of pancreatic cancer (PC) patients, in part…”
    Get full text
    Journal Article
  14. 14

    Human IGF1 pro-forms induce breast cancer cell proliferation via the IGF1 receptor by De Santi, Mauro, Annibalini, Giosuè, Barbieri, Elena, Villarini, Anna, Vallorani, Luciana, Contarelli, Serena, Berrino, Franco, Stocchi, Vilberto, Brandi, Giorgio

    Published in Cellular oncology (Dordrecht) (01-04-2016)
    “…Background IGF1 is a key regulator of tissue growth and development and has been implicated in the initiation and progression of various cancers, including…”
    Get full text
    Journal Article
  15. 15
  16. 16